Summary & Overview
HCPCS G8597: Most Recent LDL-C ≥ 100 mg/dL
Headline: HCPCS Level II code G8597 denotes elevated LDL-C (≥100 mg/dL), a key clinical quality marker
Lead: HCPCS Level II code G8597 documents a patient’s most recent low-density lipoprotein cholesterol (LDL-C) result of 100 mg/dL or higher. This marker is used in clinical care and quality measurement to identify patients at elevated cardiovascular risk and to trigger potential lipid-management actions.
What the code represents and why it matters: G8597 records an elevated LDL-C laboratory result. Nationally, tracking LDL-C levels is central to cardiovascular disease prevention strategies, performance reporting, and care coordination for patients with hyperlipidemia, diabetes, or established atherosclerotic cardiovascular disease.
Key payers covered: This analysis considers major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: The publication summarizes the clinical context for G8597, typical service settings where the code is billed, and its role in quality measurement and reporting. It outlines benchmarks and policy-relevant considerations tied to LDL-C documentation and indicates where data is not available in the input. Readers will gain a concise reference for billing and administrative teams, quality officers, and clinical leaders on the use and implications of HCPCS Level II code G8597.
Billing Code Overview
HCPCS Level II code G8597 indicates Most recent LDL-C ≥ 100 mg/dL. This code documents that the patient's most recently measured low-density lipoprotein cholesterol (LDL-C) value is 100 milligrams per deciliter or higher.
Service type: Laboratory assessment / Clinical risk documentation related to lipid management.
Typical site of service: Outpatient clinic, primary care office, cardiology clinic, or ambulatory laboratory.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A middle-aged patient with known hyperlipidemia attends a primary care visit for chronic disease management. The clinician reviews the electronic medical record and orders a fasting lipid panel. The laboratory returns an LDL-C value of 112 mg/dL. The clinician documents the most recent LDL-C as >= 100 mg/dL to support quality reporting and risk stratification. Typical workflow: office visit (evaluation and management) or telehealth encounter identifies need for lipid measurement; laboratory specimen collection at an outpatient clinic or independent lab; results reviewed in the electronic chart; clinician documents the value and updates the problem list and medication plan. Typical site of service: outpatient clinic or outpatient laboratory. Typical patient scenario: adult patient on statin therapy with suboptimal LDL-C control, requiring documentation of most recent LDL-C >= 100 mg/dL for quality metrics and care planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when an E/M visit is performed on the same day as ordering or interpreting the LDL-C result that is separately reportable |
26 |